Author: Eric Mawuli DJIRACKOR

Posted on by — Leave a comment

Kingdom Come: Deliverance II Has Received New Episode of Live Action – 80.lv

The second part of the live-action series features the main characters learning the art of medieval combat.
Kingdom Come: Deliverance II, Warhorse Studios' open-world RPG set in medieval Europe, has received a new episode of a live-action series starring the game's lead actors, Tom McKay and Luke Dale.
In the new episode, Kingdom Come: Deliverance II Official Live Action – Combat, the characters are in the Trosky region, one of the game's maps. A peculiar stranger with a crossbow interrupts their argument and forces them to visit his camp to teach them the basics of medieval combat "in a very specific manner."
In the first live-action episode, titled Kuttenberg, Luke and Tom explored in-game locations while walking along the city's medieval streets:
Kingdom Come: Deliverance II is set to release on February 4, 2025. The sequel will feature enhanced role-playing system and massive game world, being twice as big as the first part. It is even said to break the official Guinness World Record of the longest script for a videogame, set by Larian Studio's Baldur's Gate 3, as the upcoming medieval RPG has 2.2 million words, which is equal to 25 average novels.
In October, the game received a lot of negative comments over its developers' alleged plans to ship the sequel with Denuvo, a DRM technology that makes piracy harder but can hinder game performance. However, later, Warhorse officially confirmed that the sequel would be released without the said DRM.
Visit the game's Steam page and don't forget to join our 80 Level Talent platform and our new Discord server, follow us on Instagram, Twitter, LinkedIn, Telegram, TikTok, and Threads, where we share breakdowns, the latest news, awesome artworks, and more.

Start receiving our weekly newsletter
© 2024. All rights reserved. 80 level
80LV logo are registered trademarks of 80LV LLC.
We use cookies on this website to make your browsing experience better. By using the site you agree to our use of cookies.Learn more

source

Posted on by — Leave a comment

Improv, standup on tap at Great Falls Comedy Club – Lewiston Sun Journal

Sign in or Subscribe See Offers

Account Subscription: ACTIVE
Questions about your account? Our customer service team can be reached at circulation@metln.org during business hours at (207) 791-6000.
You are able to gift 5 more articles this month.
Anyone can access the link you share with no account required. Learn more.
With a Lewiston Sun Journal subscription, you can gift 5 articles each month.
It looks like you do not have any active subscriptions. To get one, go to the subscriptions page.
With a Lewiston Sun Journal subscription, you can gift 5 articles each month.
Make laughter a priority with improv comedy from Running with Scissors, and stand-up comedy featuring Ben Chadwick and Casey Watson and Chris Neuguth at 7:30 p.m. on Friday and Saturday, Dec. 27 and 28, at Great Falls Comedy Club in Auburn.
Celebrate the holidays a “Whose Line Is It Anyway?”-style show from Running with Scissors, Maine’s longest running improv troupe, on Friday.
Then headliner Ben Chadwick, featuring Chris Neuguth and host Casey Watson, will take the stage on Saturday.
Prior to COVID, Chadwick started as an open mic comic in Austin, Texas. Since moving to Maine, he has become a touring regular throughout the northeast, a house comic at Empire Comedy Club and has worked with headliners such as Joe List and Ari Shaffir.
Doors open at 7 p.m. Tickets are $20 and can be purchased in advance online at greatfallscomedyclub.com or at the door. Great Falls Comedy Club is located inside Craft Brew Underground at 34 Court St., Auburn. For more information contact the club at info@greatfallscomedyclub.com or by phone at 207-200-5366.
We invite you to add your comments. We encourage a thoughtful exchange of ideas and information on this website. By joining the conversation, you are agreeing to our commenting policy and terms of use. More information is found on our FAQs. You can modify your screen name here.
Comments are managed by our staff during regular business hours Monday through Friday as well as limited hours on Saturday and Sunday. Comments held for moderation outside of those hours may take longer to approve.

Please sign into your Sun Journal account to participate in conversations below. If you do not have an account, you can register or subscribe. Questions? Please see our FAQs.
Your commenting screen name has been updated.
Send questions/comments to the editors.

source

Posted on by — Leave a comment

5 Best Crypto Coins to Invest in Right Now as This New Layer 1 Project's Presale Continues to Rise – Brave New Coin Insights

It’s addressing some of crypto’s most frustrating real-world issues with game-changing tools like a decentralised VPN and other revolutionary applications.
Cryptocurrencies have been buzzing lately, haven’t they? With Bitcoin’s rally toward $108,000 grabbing headlines and projects like Solana and Ripple making significant ecosystem strides, the digital currency world is anything but dull.Investors are itching to identify the best coins to invest in right now, and the market’s explosive growth proves there’s never been a better time to get in on the action.
Qubetics
But here’s where it gets really exciting: a new Layer 1 project called Qubetics ($TICS) is shaking things up. Its presale has hit over $7.3 million in funding, with more than 363 million tokens already sold. What sets Qubetics apart?  Intrigued? You should be. Let’s dive into why $TICS, along with some tried-and-true heavyweights, makes this list.
Right now, Qubetics is turning heads for all the right reasons. In its 13th presale stage, $TICS has already raised $7.3 million and sold over 363 million tokens to more than 10,900 holders. Priced at $0.0342, these tokens offer a unique entry point for savvy investors looking to grab them before the price surges by 10% in the next stage this weekend.

What makes this presale so compelling? It’s not just hype—it’s Qubetics’ robust ecosystem. Unlike many crypto projects that fail to integrate seamlessly into our daily lives, Qubetics offers tools like the Multi-Chain Wallet and a decentralised VPN that directly address real-world issues. The buzz isn’t just in the numbers; it’s in the value proposition.
Imagine you’re a remote worker, bouncing between coffee shops, airports, and co-working spaces. Every time you log into public Wi-Fi, you’re rolling the dice on your personal security. That’s where Qubetics’ decentralised VPN comes in. It lets users browse the web in an encrypted environment, shielding their data from prying eyes.
But wait, there’s more. The decentralised VPN also offers users the opportunity to lease out unused bandwidth, creating a second income stream. Think about it—business owners can monetise their networks during off-hours, and gamers or freelancers can turn idle internet into cash. Qubetics is flipping the script on how we think about privacy and profitability.
Qubetics is leading the charge into the future of blockchain by solving problems that have held the industry back. With its presale flying off the shelves and tools that blend security and opportunity, $TICS is one of the best coins to invest in right now.
Bitcoin recently reached an all-time high of $108,244. But as quickly as it climbed, it tumbled to $97,000, pulled down by profit-taking and the Federal Reserve’s hawkish stance on rate cuts. Despite the dip, Bitcoin remains the market’s cornerstone, continuing to weather macroeconomic pressures with resilience.
Long-term holders are sticking with Bitcoin, a testament to its role as digital gold. Plus, with institutions like BlackRock throwing their weight behind Bitcoin ETFs, the future for BTC looks as strong as ever.
Bitcoin is a no-brainer. It’s the OG crypto, the bellwether of the market, and a store of value like no other. Whether you’re a first-timer or a seasoned pro, BTC is one of the best coins to invest in right now.
Ripple’s legal troubles may have dominated headlines, but the launch of its RLUSD stablecoin has reminded the world that XRP is here to stay. This move positions Ripple as a key player in cross-border payments and financial stability.
Despite regulatory uncertainty, Ripple’s utility in real-world transactions makes it a powerful contender. Investors and institutions alike are recognising its potential to disrupt traditional finance.
XRP isn’t just surviving—it’s thriving. Its technology is setting standards in cross-border transactions, making it a smart pick for anyone seeking the best coins to invest in right now.
Solana recently faced a tough week, slipping below $196. But here’s the kicker: its ecosystem remains vibrant, boasting one of the highest transaction speeds in the industry. Developers love Solana for its low fees and scalability, which keeps it in the spotlight.
While volatility has shaken short-term holders, the network’s Total Value Locked (TVL) continues to attract DeFi enthusiasts. With growing adoption and technical strength, Solana is far from down and out.
Solana is a fighter. Despite market challenges, its tech is some of the best in the game. It’s undoubtedly one of the best coins to invest in right now.
Binance Coin, the powerhouse token of the Binance ecosystem, is riding high on its robust utility. From trading fee discounts to powering Binance Smart Chain projects, BNB is at the centre of a thriving ecosystem.
Even with regulatory hurdles, Binance remains a global leader in crypto exchanges. BNB holders are reaping the benefits of a token that delivers both utility and growth.
BNB is more than a coin; it’s a gateway to one of the most extensive ecosystems in crypto. That’s why it’s one of the best coins to invest in right now.

Qubetics, Bitcoin, Ripple, Solana, and Binance Coin stand out as the best coins to invest in right now. Each brings something unique to the table, from revolutionary new tech like Qubetics’ decentralised VPN to the tried-and-true reliability of Bitcoin and the ecosystem strengths of BNB.
Don’t wait too long to jump in—opportunities like these don’t stick around forever. The Qubetics presale won’t last much longer, and the next stage will see a price hike. Act now, and you could be part of the next big wave in cryptocurrency innovation.
Qubetics
Qubetics: https://qubetics.com
Telegram:https://t.me/qubetics
Twitter:https://x.com/qubetics
This is a sponsored article. Opinions expressed are solely those of the sponsor and readers should conduct their own due diligence before taking any action based on information presented in this article.
BNC AdvertisingBrave New Coin reaches 500,000+ engaged crypto enthusiasts a month through our website, podcast, newsletters, and YouTube. Get your brand in front of key decision-makers and early adopters. Don’t wait – Secure your spot and drive real impact in Q4. Find out more today!
21 Dec 2024
21 Dec 2024
21 Dec 2024
|21 Dec 2024|Press Releases|
|21 Dec 2024|Press Releases|
|21 Dec 2024|Press Releases|
|21 Dec 2024|News|
|21 Dec 2024|News|
Auckland / Melbourne / London / New York / Tokyo
A Techemy company
PO Box 90497, Victoria St West, Auckland Central, 1010, New Zealand.
© 2024 Brave New Coin. All Rights Reserved.

source

Posted on by — Leave a comment

Rooks: The only solution to our health care dilemma – Seacoastonline.com

I had emergency surgery awhile back, and the results were so positive that when I went for my follow-up visit there was little to say. So I asked the surgeon how he would untangle the grievous mess that is the U.S. health care system.
“Take the profit motive out of medicine,” was the response. He’s right, but it’s easier said than done; still, we must try.
A frisson went through those who control the giant profit-making health care companies when a patient with a murderous grudge gunned down United Healthcare CEO Brian Thompson in Midtown Manhattan on Dec. 4 – especially after many in the notorious national chat room suggested he might have had it coming.
Murder is never justified, but how did we end up in this dark place, where despite all the billions of dollars poured into the system daily, we’re more frustrated than ever?
The statistics are almost too familiar, but bear repeating: The U.S. has by far the world’s most expensive system, yet has dismal rankings for overall health – and life expectancy in many areas has actually fallen.
One explanation is how two national systems developed in the U.S. and Canada, its nearest and most familiar neighbor.
In both nations, a program called Medicare started in the mid-1960s, but quickly diverged.
In Canada, the system covers everyone. No patient gets a bill; costs are negotiated and allocated among providers, with government playing a leading regulatory role.
As in any system, there are complaints – especially the waits for elective surgery that Americans probably wouldn’t tolerate. But satisfaction among Canadians is far, far higher than ours, and costs are much lower.
In the U.S., Medicare covers only those 65 and up. It’s “single payer,” meaning the federal government pays the bills and raises tax revenue to support it.
Yet since the early 2000s, Medicare has been invaded by private interests – both through the “Advantage plans” government subsidizes even though it could offer the same benefits directly, and Part D prescription drug coverage, which – at Republican insistence – allows manufacturers to charge the taxpayer whatever they want.
Only with President Biden’s foot-in-the-door bill requiring price negotiations on a few high-price drugs have we seen any relief, but drug costs will remain a major problem.
Then there’s the enormous bulking-up of provider networks, with larger and larger companies buying up more and more hospitals and physician practices.
Even in Maine, where non-profit “charitable” organization remains the model, just two companies – Maine Health in Portland and Northern Light in Bangor – control the vast majority of care.
We should recall that these hospital consortiums are private entities whose decisions are opaque to the public. What maternity wards remain open, what staffing levels are maintained, what new services are offered is largely private and unaccountable, not reviewed by any public agency.
In the end, we have huge providers and drug companies trying to maximize revenues, opposed by insurers who try to contain costs largely by denying claims.
It’s no secret who’s being squeezed – patients and their doctors.
Everywhere, doctors say they can no longer select the most effective treatment; instead, they prescribe what insurers will pay for, a constantly changing target.
The Affordable Care Act of 2009, the most significant change in the system since Medicare began in 1965, and President Obama’s signature achievement, did tackle the biggest problem of the day – the uninsured. But it did so by vastly increasing those on private insurance, perhaps accelerating the consolidation that elevates the “profit motive” ever higher.
We’ll never fundamentally change the system until we recognize that we need a national system under public control, just like every other advanced country.
Calling it “single-payer” is perhaps the worst euphemism ever coined, meaningless to the average person. We can call it “national” or “universal” or even “government directed” but it’s the only way to reclaim our rights.
Such changes are a remote possibility with the incoming administration, since Donald Trump rarely mentions health care, and has no plan beyond the vestigial Republican impulse to “repeal Obamacare,” which is never going to happen.
Except for recanting her earlier support for “single payer,” Kamala Harris had little to offer, either.
Proponents of national health care should get busy developing a real plan, showing how Medicare can be purged of profit-seeking, private insurance contained, drug prices regulated and state-run Medicaid programs, which vary widely, made subject to federal standards.
Then we’d have something closer to “Medicare for All” – no longer just a slogan – and finally achieve something for all Americans closer to Canada’s efficient delivery system.
It may seem impossible, but we’ve confronted and solved difficult problems before. Let’s face it: Nothing changes until we demand change.
Douglas Rooks has been a Maine editor, columnist and reporter for 40 years. He is the author of four books, most recently a biography of U.S. Chief Justice Melville Fuller, and welcomes comment at drooks@tds.net

source